The Valley Desk

NCT07227285 · Interventional trial

Long-term Follow-up Study of Patients Who Received EG110A, a Non-replicative Herpes Simplex Virus 1-derived Gene Therapy

Overall registry status Not yet recruiting

Phase 1 · Phase 2

Conditions Spinal Cord Injury, Urinary Bladder, Overactive

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov